The latest financial statement is for the quarter ending 2026-03-31.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income | 6,800 | -54,600 | 51,200 | 56,000 |
| Stock-based compensation expense | 1,900 | 5,300 | 4,800 | 6,100 |
| Depreciation and amortization | 23,500 | 23,500 | 23,400 | 48,900 |
| Change in fair value of contingent obligations, net | - | 0 | 0 | 0 |
| Amortization of deferred financing costs | 1,800 | 2,600 | 2,500 | 4,700 |
| Deferred income taxes | -4,500 | 1,500 | -10,200 | 4,700 |
| Noncash gain on sale of business | - | 12,200 | -12,200 | - |
| Noncash loss on assets held for sale | 12,200 | - | - | -12,200 |
| Change in fair value of warrant liability | -8,400 | 7,300 | 4,800 | -6,600 |
| Goodwill impairment | - | 0 | - | - |
| Impairment of long-lived assets | - | 12,200 | 0 | 0 |
| Loss on disposal of assets | -800 | -1,000 | -2,200 | -1,300 |
| Other | 3,900 | -9,100 | -400 | 9,100 |
| Accounts receivable | 38,900 | -51,900 | 71,600 | -45,200 |
| Inventories | -15,800 | -14,200 | 17,600 | 26,900 |
| Prepaid expenses and other assets | 500 | 15,400 | 2,100 | -29,200 |
| Accounts payable | -14,400 | 11,400 | -4,000 | -15,800 |
| Accrued expenses and other liabilities | -1,800 | 16,800 | 1,300 | -28,300 |
| Long-term incentive plan accrual | 400 | 800 | 700 | 1,600 |
| Accrued compensation | -20,200 | 4,500 | 4,500 | -26,300 |
| Income taxes receivable and payable, net | 4,600 | -6,300 | 6,200 | -1,600 |
| Contract liabilities | 3,200 | 4,100 | 1,200 | -100 |
| Net cash used in operating activities | -33,800 | 77,700 | -2,300 | 95,200 |
| Purchases of property, plant and equipment | 2,400 | 3,900 | 3,400 | 6,500 |
| Proceeds from sale of property, plant and equipment | 0 | 0 | 0 | 38,200 |
| Milestone payments from prior asset divestiture | 0 | 0 | 0 | -50,000 |
| Proceeds from sale of business | - | 0 | 0 | - |
| Purchase of convertible note receivable | 0 | 0 | 0 | 5,000 |
| Net cash provided by (used in) investing activities | -2,400 | -3,900 | -3,400 | 76,700 |
| Proceeds from the issuance of debt, net of lender fees | - | 0 | 0 | - |
| Proceeds allocated to warrants issued in conjunction with debt | - | 0 | 0 | - |
| Proceeds allocated to common stock issued in conjunction with debt | - | 0 | 0 | - |
| Principal payments on term loan facility | - | 100,000 | 0 | 0 |
| Proceeds from revolving credit facility | - | 0 | 0 | 0 |
| Principal payments on revolving credit facility | - | 0 | 0 | 0 |
| Debt issuance costs | - | 0 | 0 | 0 |
| Proceeds from issuance of common stock upon exercise of stock options | 400 | -1,000 | 1,000 | - |
| Repurchase of debt | - | 1,800 | 6,900 | - |
| Prepayment premium on debt principal payment | - | 3,800 | - | - |
| Purchases of treasury stock | 9,000 | 9,100 | 8,900 | 6,900 |
| Proceeds from stock-based compensation activity | 0 | 0 | -800 | 800 |
| Taxes paid for stock-based compensation activity | 2,800 | 400 | 300 | 700 |
| Net cash used in financing activities | -11,400 | -113,900 | -15,900 | -6,800 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 0 | 0 | -200 | 300 |
| Net change in cash, cash equivalents and restricted cash | -47,600 | -40,100 | -21,800 | 165,400 |
| Cash, cash equivalents and restricted cash, beginning of period | 209,100 | 249,200 | 105,600 | - |
| Cash, cash equivalents and restricted cash, end of period | 161,500 | 209,100 | 249,200 | - |